CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

Tata Motors shares have gained 1.64 per cent in 2024 so far against 28.22 per cent rise in the BSE Auto index during the same ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

(Reuters) - CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS – Research Report), Amicus (FOLD – Research ...

CVS Health faced mixed results in its latest earnings report, revealing revenue growth amid segment struggles.

Good morning and thank you all for attending the CVS Health third-quarter 2024 earnings call and webcast. My name is Brika ...

Meanwhile, among the sector's biggest decliners were hospital operators, with HCA Healthcare Inc.'s stock (HCA) shedding 4.6%, Universal Health Services Inc. shares (UHS) falling 3.7% and shares of ...

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

Motilal Oswal is bullish on Tube Investments of India has recommended buy rating on the stock with a target price of Rs 4750 in its research report dated 5, 2024.